# Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

> **NCT02021019** · NA · COMPLETED · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 3 (actual)

## Conditions studied

- End-stage Renal Disease
- Hypertension

## Interventions

- **PROCEDURE:** Renal Denervation

## Key facts

- **NCT ID:** NCT02021019
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021019, "Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02021019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*